Stock Markets May 26, 2026 07:06 AM

Quantinuum Seeks Up to $12.7 Billion Valuation in U.S. IPO

Quantum computing spinout from Honeywell aims to raise about $1.05 billion with Nasdaq listing under symbol QNT

By Ajmal Hussain

Quantinuum, the quantum computing company that emerged from Honeywell’s separation and a merger with Cambridge Quantum, is pursuing a U.S. initial public offering that would value the firm at as much as $12.7 billion. The Broomfield, Colorado-based company plans to sell roughly 21.05 million shares at $45 to $50 each to raise up to $1.05 billion, following a private funding round that valued the business at $10 billion.

Quantinuum Seeks Up to $12.7 Billion Valuation in U.S. IPO

Key Points

  • Quantinuum is targeting a valuation of up to $12.7 billion in its U.S. IPO, aiming to sell roughly 21.05 million shares at $45 to $50 each.
  • The offering could raise up to $1.05 billion and follows a private funding round that valued the company at $10 billion.
  • The firm was formed in 2021 after a separation from Honeywell and a merger with Cambridge Quantum; it will list on Nasdaq under the symbol QNT with J.P. Morgan and Morgan Stanley as joint lead active book-runners.
  • Sectors seeing investor interest that may support listings like Quantinuum include AI infrastructure, defense and critical technologies.

Quantinuum has filed to go public in the United States with an indicative valuation of up to $12.7 billion, the company disclosed on Tuesday. The offering is structured around the sale of approximately 21.05 million shares priced between $45 and $50 per share, which would allow Quantinuum to raise up to $1.05 billion if the full range is taken up.

The business, headquartered in Broomfield, Colorado, last secured private funding at a $10 billion valuation. That prior round established a baseline that the IPO would exceed should the company achieve the upper end of its current price range.

Quantinuum was created in 2021 through a separation from Honeywell combined with a merger involving Cambridge Quantum. The company's board chair is Honeywell's chief executive, Vimal Kapur, while day-to-day leadership is headed by Rajeeb Hazra, who previously served at Intel. The planned public listing will appear on the Nasdaq exchange under the ticker symbol "QNT."

Financial institutions J.P. Morgan and Morgan Stanley have been named as joint lead active book-running managers for the transaction. The filing and market approach come at a time when new public listings are attracting investor interest, particularly in areas deemed strategically important. The sectors specifically cited as drawing renewed backing include AI infrastructure, defense and other critical technologies. The company and its advisers are seeking to tap that investor appetite amid continuing geopolitical uncertainty that market participants say has not dampened interest in these categories.

The IPO proposal would convert private backing into public equity while positioning Quantinuum to access broader capital markets. The filing materials indicate the company's intention to list publicly rather than provide detail on how the proceeds will be allocated. Quantinuum's leadership and the choice of underwriters suggest the offering is being structured to reach institutional investors comfortable with high-technology and strategic-technology plays.


Summary

Quantinuum plans a U.S. IPO that could value the firm at up to $12.7 billion by selling about 21.05 million shares at $45 to $50 apiece, aiming to raise up to $1.05 billion. The company, formed after Honeywell separated and merged with Cambridge Quantum in 2021, will list on Nasdaq as QNT with J.P. Morgan and Morgan Stanley as joint book-runners.

Risks

  • Market demand for the IPO may be affected by geopolitical uncertainty and shifts in investor appetite for strategic-technology sectors - this could influence pricing and subscription levels.
  • The company’s planned valuation is higher than its most recent private funding valuation of $10 billion, which introduces execution risk if public investors value the company differently.
  • The filing does not detail use of proceeds, so investors will need to rely on the company’s disclosures for clarity on capital allocation and growth strategy.

More from Stock Markets

Anthropic Urges Joint Mechanism to Slow Frontier AI if Self-Improvement Outpaces Risk Controls Jun 4, 2026 S&P Global Upholds Fast-Entry Rules Ahead of SpaceX Public Debut Jun 4, 2026 Insperity Shares Climb After CEO Buys 233,000 Shares Jun 4, 2026 SpaceX Signals Firmness on $135 IPO Price as Roadshow Begins Jun 4, 2026 CME Chief Warns CFTC Approval of Perpetual Crypto Futures Could Create Systemic Risk Jun 4, 2026